EGFR +ve/ PTEN -ve PTEN+ve/ EGFR -ve EGFR+ve/ PTEN+ve EGFR-ve/ PTEN-ve Overall Mutations Survival (months)
n n n n n
Age (years) < 40 3 42.9 0 0.0 0 0.0 4 57.1 3/7 42.9 16
≥ 40 7 21.2 4 12.1 3 9.1 19 57.6 14/33 42.4 14
Gender Male 8 28.6 2 7.1 2 7.1 16 57.1 12/28 42.9 15
Female 2 16.7 2 16.7 1 8.3 7 58.3 5/12 41.7 15
Table 6: Mutations and survival across age and gender.